Investor Relations

VBL Therapeutics (Nasdaq: VBLT) is developing targeted therapies for people living with immune-inflammatory diseases.

Events & Presentations

More events are coming soon.

Press Releases

May 15, 2023
VBL Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update
Read More
March 14, 2023
VBL Therapeutics Reports Full Year 2022 Financial Results and Provides Corporate Update
Read More

Corporate Presentation

More information is coming soon.
May 16, 2023 11:21 AM EDT

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Stock Chart